BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343 [PMID: 16733849 DOI: 10.3748/wjg.v12.i21.3338]
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3338.htm
Number Citing Articles
1
Katarzyna Zdanowicz, Monika Kowalczuk-Kryston, Witold Olanski, Irena Werpachowska, Wlodzimierz Mielech, Dariusz Marek Lebensztejn. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary StudyBiomolecules 2022; 12(5): 710 doi: 10.3390/biom12050710
2
Pamela Valva, Daniela A Ríos, Elena De Matteo, Maria V Preciado. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageWorld Journal of Gastroenterology 2016; 22(4): 1367-1381 doi: 10.3748/wjg.v22.i4.1367
3
Piotr Adrian Klimiuk, Izabela Domysławska, Stanisław Sierakowski, Justyna Chwiećko. Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockersRheumatology International 2015; 35(4): 749 doi: 10.1007/s00296-014-3112-1
4
Gloria Sanchez-Antolín, Carolina Almohalla-Alvarez, Pilar Bueno, Raquel Almansa, Verónica Iglesias, Lucia Rico, Alicia Ortega, Eva Muñoz-Conejero, Felix García-Pajares, Jesus F. Bermejo-Martin, Matias A Avila. Evidence of Active Pro-Fibrotic Response in Blood of Patients with CirrhosisPLOS ONE 2015; 10(8): e0137128 doi: 10.1371/journal.pone.0137128
5
Lorena Zuliani-Alvarez, Anna M. Piccinini. A virological view of tenascin-C in infectionAmerican Journal of Physiology-Cell Physiology 2023; 324(1): C1 doi: 10.1152/ajpcell.00333.2022
6
Morten A. Karsdal, Kim Henriksen, Federica Genovese, Diana J. Leeming, Mette J. Nielsen, Bente J. Riis, Claus Christiansen, Inger Byrjalsen, Detlef Schuppan. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetesDiabetologia 2017; 60(1): 50 doi: 10.1007/s00125-016-4094-1
7
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
8
M Kasprzycka, C Hammarström, G Haraldsen. Tenascins in fibrotic disorders—from bench to bedsideCell Adhesion & Migration 2015; 9(1-2): 83 doi: 10.4161/19336918.2014.994901
9
Judith Flores-Calderón, Segundo Morán-Villota, Guillermo Ramón-García, Berenice González-Romano, María del Carmen Bojórquez-Ramos, Laura Cerdán-Silva, Pablo Hernández-Frías. Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter studyAnnals of Hepatology 2012; 11(3): 364 doi: 10.1016/S1665-2681(19)30933-0
10
Yue Chen, Jia‑En Yang, Jing‑Mo Tang, Qian‑Guo Mao, Qi‑Zhong Zheng, Ying Zheng. Predictive value of plasmacytoid dendritic cells and Toll‑like receptor‑9 regarding the treatment efficacy of interferon‑α in HBeAg‑positive chronic hepatitis B patientsExperimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.8161
11
Solange Heller, Pedro Valencia-Mayoral. Treatment of Viral Hepatitis in ChildrenArchives of Medical Research 2007; 38(6): 702 doi: 10.1016/j.arcmed.2006.09.005
12
Martin Degen, Florence Brellier, Susanne Schenk, Robert Driscoll, Khalil Zaman, Roger Stupp, Luigi Tornillo, Luigi Terracciano, Ruth Chiquet‐Ehrismann, Curzio Rüegg, Walter Seelentag. Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patientsInternational Journal of Cancer 2008; 122(11): 2454 doi: 10.1002/ijc.23417
13
Valdas Banys, Goda Aleknavičiūtė-Valienė. Clinical importance of laboratory biomarkers in liver fibrosisBiochemia medica 2022; 32(3): 346 doi: 10.11613/BM.2022.030501
14
K. Patel, Y. Benhamou, E. M. Yoshida, K. D. Kaita, S. Zeuzem, M. Torbenson, E. Pulkstenis, G. M. Subramanian, J. G. McHutchison. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis CJournal of Viral Hepatitis 2009; 16(3): 178 doi: 10.1111/j.1365-2893.2008.01062.x
15
Pamela Valva, Paola Casciato, Juan M. Diaz Carrasco, Adrian Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic InfectionPLoS ONE 2011; 6(8): e23218 doi: 10.1371/journal.pone.0023218
16
Andrea Sabina Llera, Maria Romina Girotti, Lorena Gabriela Benedetti, Osvaldo Luis Podhajcer. Matricellular proteins and inflammatory cells: A task force to promote or defeat cancer?Cytokine & Growth Factor Reviews 2010; 21(1): 67 doi: 10.1016/j.cytogfr.2009.11.010